Groupe pharmaceutique · États-Unis
Baxter
Un groupe de 34 sociétés, avec 1 256 médicaments dans 11 pays.
Structure du groupe
34 sociétés dans 13 pays
Chargement…
Groupe pharmaceutique · États-Unis
Un groupe de 34 sociétés, avec 1 256 médicaments dans 11 pays.
34 sociétés dans 13 pays
Un compte gratuit pour les apps Prognia : Ward pour réviser, Osler pour des réponses cliniques avec leurs sources, et le réseau pour retrouver vos collègues.
Les groupes sont constitués par Prognia à partir des noms publiés par les autorités et des liens entre sociétés ; ils ne reflètent pas une structure juridique officielle.
Tous les médicaments de toutes les sociétés du groupe, les actuels d’abord.
1–25 sur 1 256
| Médicament | Substance active | Pays | Statut | Autorisation |
|---|---|---|---|---|
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION50 mg / ml + 4 mg / ml · Solution | Dextrose, Lidocaine | Canada | Commercialisé | 1990 |
| 0.9% SODIUM CHLORIDE INJECTION, USP900 mg / 100 ml · Solution | Sodium chloride | Canada | Commercialisé | 1982 |
| 0.9% SODIUM CHLORIDE IRRIGATION, USP900 mg / 100 ml · Solution | Sodium chloride | Canada | Commercialisé | 1989 |
| 10% DEXTROSE INJECTION, USP10 g / 100 ml · Solution | Dextrose | Canada | Commercialisé | 1997 |
| 10 mEq Potassium Chloride in 5% Dextrose and 0.33% Sodium Chloride Injection, USP50 g/L + 1.5 g/L + 3.3 g/L · Injection | Hydrous dextrose, Potassium chloride, Sodium chloride | Singapour | Autorisé | 2006 |
| 12% SODIUM CHLORDIE PROCESSING SOLUTION12 g / 100 ml · Solution | Sodium chloride | Canada | Commercialisé | 1991 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP3.3 g / 100 ml + 150 mg / 100 ml + 300 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Commercialisé | 1978 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 150 mg / 100 ml + 900 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Commercialisé | 1990 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP5 g / 100 ml + 150 mg / 100 ml · Solution | Dextrose, Potassium chloride | Canada | Commercialisé | 1989 |
| 20% PROSOL2.76 g / 100 ml + 1.96 g / 100 ml + 0.76 g / 100 ml + 1.02 g / 100 ml + 2.06 g / 100 ml + 1.18 g / 100 ml + 1.08 g / 100 ml + 0.6 g / 100 ml + 1.08 g / 100 ml + 1.35 g / 100 ml + 1 g / 100 ml + 1.34 g / 100 ml + 1.02 g / 100 ml + 0.98 g / 100 ml + 0.32 g / 100 ml + 0.05 g / 100 ml + 1.44 g / 100 ml · Liquid | Alanine, Arginine, Dl-methionine, Glutamic acid, Glycine, Histidine, Isoleucine, L-aspartic acid, Amino acids, Lysine, Phenylalanine, Proline, Serine, Threonine, Tryptophan, Tyrosine, Valine | Canada | Commercialisé | 1996 |
| 20% SODIUM CHLORIDE INJECTION, BP20 % / w/v · Solution | Sodium chloride | Canada | Commercialisé | 2022 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP150 mg / 100 ml + 900 mg / 100 ml · Solution | Potassium chloride, Sodium chloride | Canada | Commercialisé | 1989 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 150 mg / 100 ml + 450 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Commercialisé | 1989 |
| (40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP300 mg / 100 ml + 900 mg / 100 ml · Liquid | Potassium chloride, Sodium chloride | Canada | Commercialisé | 1989 |
| (40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP5 g / 100 ml + 300 mg / 100 ml · Solution | Dextrose, Potassium chloride | Canada | Commercialisé | 1989 |
| (40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP3.3 g / 100 ml + 300 mg / 100 ml + 300 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Commercialisé | 1978 |
| (40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 300 mg / 100 ml + 450 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Commercialisé | 1989 |
| 5% DEXTROSE INJECTION, USP5 g / 100 ml · Solution | Dextrose | Canada | Commercialisé | 1990 |
| 70% DEXTROSE INJECTION USP70 g / 100 ml · Solution | Dextrose | Canada | Commercialisé | 1995 |
| ACETAMINOPHEN INJECTION10 mg / ml · Solution | Paracetamol | Canada | Commercialisé | 2023 |
| Aciclovir Baxter 25 mg/ml, concentraat voor oplossing voor intraveneuze infusieConcentraat voor oplossing voor infusie | Aciclovir | Pays-Bas | Autorisé | 2013 |
| ACIDO TRANEXAMICO BAXTER 100 MG/ML SOLUCION INYECTABLE EFG100 mg/ml · Solucion inyectable y para perfusion | Tranexamic acid | Espagne | Autorisé | 2020 |
| ACQUA PER PREPARAZIONI INIETTABILI BAXTERSolvente per uso parenterale | Acqua preparazioni iniettabili | Italie | Autorisé | |
| AERRANELiquido per suffumigi | Isoflurane | Italie | Autorisé | |
| AERRANE 100% LÍQUIDO PARA INHALACIÓN DEL VAPOR250 ml · Solución para inhalación del vapor | Isoflurane | Espagne | Commercialisé | 1995 |
Où ses médicaments sont enregistrés ou fabriqués, et combien sont actuels.
| Pays | Médicaments | Actuels | Anciens | Sociétés |
|---|---|---|---|---|
| Canada | 397 | 141 | 256 | SociétésTous les médicaments |
| Arabie saoudite | 243 | 243 | 0 | SociétésTous les médicaments |
| États-Unis | 224 | 224 | 0 | SociétésTous les médicaments |
| Brésil | 85 | 29 | 56 | SociétésTous les médicaments |
| Espagne | 83 | 71 | 12 | SociétésTous les médicaments |
| Pays-Bas | 83 | 83 | 0 | SociétésTous les médicaments |
| Italie | 52 | 52 | 0 | SociétésTous les médicaments |
| Singapour | 45 | 45 | 0 | SociétésTous les médicaments |
| Croatie | 25 | 25 | 0 | SociétésTous les médicaments |
| Roumanie | 14 | 0 | 14 | SociétésTous les médicaments |
| Union européenne (EMA) | 5 | 3 | 2 | SociétésTous les médicaments |
Également dans les registres : France, Royaume-Uni, Serbie
Les groupes ATC auxquels appartiennent la plupart de ses médicaments, les plus importants d’abord.
Les substances actives présentes dans la plupart de ses médicaments.
Comment les registres l’écrivent, normalisé : sans forme juridique, accents ni majuscules.
Compilé par Prognia à partir des registres publics de médicaments et d’entreprises ci-dessous. Aucun logo n’est utilisé.
Les groupes sont constitués par Prognia à partir des noms publiés par les autorités et des liens entre sociétés ; ils ne reflètent pas une structure juridique officielle.
Source: European Medicines Agency (EPAR data).
Licence : EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence : AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence : Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence : Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence : Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence : Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence : Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence : Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence : Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence : AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence : AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence : BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; Crown copyright MHRA factual register
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence : Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence : Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence : Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence : Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence : Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence : Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence : Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Saudi Food and Drug Authority (SFDA), local human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence : Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licence : Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence : Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence : FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Signaler une erreur ou demander un retraitLes corrections de la société elle-même sont les bienvenues.
Baxter : veillez à l’exactitude de vos médicaments sur Prognia, voyez comment les professionnels les utilisent et répondez à leurs questions. Un appel de 20 minutes, en anglais.
Réserver un appelDes groupes pharmaceutiques connus, chacun avec toutes ses sociétés.
Classés selon leur nombre de médicaments.